Carpal Tunnel Syndrome Treatment in India & UAE — Expert Surgical Release
Carpal tunnel syndrome treatment in India from $800. Endoscopic & open carpal tunnel release by expert hand surgeons. 96% success. Same-day discharge. Book with GAF Healthcare.
Estimated cost: $800 – $2,000 · Average stay: Same day – 1 day
Carpal tunnel syndrome (CTS) is the most common peripheral nerve entrapment condition in the world, affecting an estimated 3–6% of the adult population. It occurs when the median nerve — which passes through the carpal tunnel, a narrow fibro-osseous channel at the wrist formed by the carpal bones and the transverse carpal ligament — is compressed by swelling, thickening of the flexor tendon synovium, or anatomical narrowing. The resulting median nerve compression causes the classic symptoms: numbness and tingling in the thumb, index, middle, and radial half of the ring finger (the median nerve sensory distribution); nocturnal hand pain that wakes the patient; and in advanced or chronic cases, weakness and wasting of the thenar muscles at the base of the thumb.
CTS disproportionately affects women (3:1 female to male ratio), individuals who perform repetitive wrist-intensive tasks (keyboard workers, assembly line workers, musicians), pregnant women (from fluid retention), and patients with metabolic conditions that cause flexor synovial thickening — hypothyroidism, diabetes mellitus, rheumatoid arthritis, and acromegaly. Correctly identifying and managing any underlying systemic condition alongside treating the CTS itself is an important part of comprehensive management.
India and the UAE have hand surgery specialists and general orthopaedic and plastic surgeons experienced in both endoscopic and open carpal tunnel release, with same-day discharge and costs 60–75% below equivalent private surgery in the UK or USA. For patients whose symptoms have not responded to splinting and corticosteroid injection — or who have any thenar wasting indicating motor nerve damage — surgical release is the definitive treatment.
Diagnosing Carpal Tunnel Syndrome
The clinical diagnosis of CTS rests on the symptom history (nocturnal numbness in the median nerve distribution, relief with shaking the hand — the "flick sign"), the Phalen's test (wrist flexion for 60 seconds reproducing symptoms), and Tinel's sign (percussion over the carpal tunnel at the wrist reproducing tingling in the fingers). In clinical practice, the diagnosis is confirmed with nerve conduction studies (NCS) and electromyography (EMG), which measure the speed of electrical conduction across the carpal tunnel — a slowing in sensory and/or motor latency across the wrist confirms median nerve entrapment and grades its severity (mild, moderate, or severe).
CTS is graded clinically: mild (intermittent numbness and tingling, no motor deficit, normal or mildly abnormal NCS); moderate (persistent numbness, beginning weakness of thumb opposition and tip pinch, abnormal NCS); severe (constant numbness, significant thenar wasting, severe NCS delay or absent response). Surgical decompression is most urgent in moderate and severe CTS to prevent permanent nerve damage. In mild CTS, a trial of nocturnal wrist splinting (holding the wrist in the neutral position to reduce tunnel pressure during sleep) and a single corticosteroid injection into the carpal tunnel is appropriate first-line management — surgical release is offered if these measures fail after 3–6 months.
Carpal Tunnel Release Surgery
Carpal tunnel release surgery divides the transverse carpal ligament — the tight roof of the carpal tunnel — to decompress the median nerve. The operation can be performed under local anaesthesia (wrist block or WALANT — wide awake local anaesthesia no tourniquet technique) as a day procedure taking 15–20 minutes.
Open carpal tunnel release (OCTR): a 2–3 cm incision is made in the palm from the distal wrist crease toward the ring finger base. The transverse carpal ligament is divided under direct vision; the median nerve is inspected and any scar tissue adherent to the nerve is carefully cleared. The skin is closed with fine sutures. OCTR is associated with a slightly longer scar tenderness recovery (the palm scar can be sensitive for 3–6 months) but is technically straightforward and highly effective.
Endoscopic carpal tunnel release (ECTR): using the Agee single-portal or Chow two-portal technique, a small camera and cutting blade are inserted through a 1 cm wrist incision; the ligament is divided from its deep surface under camera guidance without opening the palm. ECTR has faster return to grip strength, less palmar scar tenderness, and earlier return to work compared with OCTR, though the two techniques have equivalent long-term outcomes. The choice between OCTR and ECTR depends on surgeon training, patient anatomy, and local availability.
Both techniques are equally effective for all grades of CTS. The operation is performed as a day case; the patient goes home the same day.
Procedure Steps
- Nerve conduction studies confirm CTS grade; thyroid function, blood glucose, and rheumatoid factor checked where indicated
- WALANT (wide awake local anaesthesia) or wrist block administered; tourniquet applied (optional)
- Incision (open) or portal placement (endoscopic); transverse carpal ligament identified
- Transverse carpal ligament divided completely under direct vision or endoscopic guidance
- Median nerve inspected; any adhesions cleared; wound irrigated
- Skin closure with absorbable sutures; bulky pressure dressing applied
- Finger and thumb movement exercises started on the day of surgery
Cost Comparison Worldwide
Country — Range — Savings
--- — --- — ---
USA — $3,000 – $6,000 — Save up to 85%
UK — £1,500 – £3,500 — Save up to 75%
Australia — AUD 3,000 – 5,500 — Save up to 80%
UAE — $2,000 – $4,500 — Save up to 70%
India — $800 – $2,000 — Best value
Carpal tunnel release in the USA costs $3,000–$6,000 in an ambulatory surgery centre. In India, the complete procedure — surgeon fee, local anaesthesia, day surgery facility, and follow-up — costs $800–$2,000 per hand. For patients who require bilateral release (both hands — common in CTS), both hands can be operated on in the same session or on consecutive days, with total costs of $1,400–$3,500 for bilateral release in India.
Recovery & Follow-up
Recovery from carpal tunnel release is rapid. The bulky dressing is replaced with a small wound dressing at 48 hours. Finger and wrist movement are encouraged from day 1 to prevent stiffness. Sutures are removed at 10–14 days. Light activities of daily living (eating, writing, typing) resume within 2–7 days for most patients. Return to heavy manual work takes 4–6 weeks. Grip strength returns to near-normal by 3 months.
Numbness and tingling typically improve immediately after surgery and continue to recover over 3–6 months as the nerve regenerates. In severe CTS with significant thenar wasting, motor function recovery is slower and may be incomplete if the nerve has been chronically compressed — which is why early surgical intervention is important once conservative measures have failed.
Recovery Tips
- Begin finger flexion and extension exercises immediately after surgery to prevent stiffness
- Elevate the hand above heart level for the first 48 hours to reduce swelling
- Keep the dressing clean and dry for 48 hours; then a small waterproof dressing is sufficient
- Scar massage with a bland moisturiser from 3 weeks softens the palmar scar and reduces tenderness
- Avoid gripping heavy objects for 4 weeks; light grip is fine from day 1
- Report any new weakness, increased swelling, or wound redness promptly
Risks & Complications
Carpal tunnel release is a safe, high-success-rate procedure. Risks include: incomplete release (if the ligament is not fully divided — requires revision); recurrence (rare — 3–5% over 10 years, usually from re-adherence of scar tissue); palmar scar tenderness (the most common complaint after OCTR — usually resolves by 3–6 months with scar massage); nerve injury (rare — the median nerve palmar cutaneous branch, which lies just ulnar to the incision, can be injured causing persistent palmar numbness; the motor recurrent branch of the median nerve can be injured causing weakness of thumb opposition — extremely rare in experienced hands); bowstringing (if the flexor retinaculum is divided without maintaining some integrity — rare with modern technique); and reflex sympathetic dystrophy (rare).
Why GAF Healthcare
GAF Healthcare's partner hand surgery teams perform carpal tunnel release in high volumes as part of a comprehensive hand and peripheral nerve surgery programme. Both OCTR and ECTR are offered at our partner centres; the choice is made on an individual clinical basis after examination and nerve conduction study review. All NCS and EMG reports can be submitted digitally before the patient travels for pre-operative assessment, saving time on arrival.
Frequently Asked Questions
How do I know if I need surgery for carpal tunnel syndrome?
Surgery is recommended when: conservative measures (wrist splinting, corticosteroid injection) have failed after 3–6 months; symptoms are moderate or severe and are significantly affecting work, sleep, and daily activities; nerve conduction studies show moderate or severe median nerve compression; or there is any thenar muscle wasting, indicating that motor nerve fibres are being damaged. If you have thenar wasting, early surgery is important — waiting further risks permanent muscle damage that may not recover even after a successful decompression.
Can both hands be operated on at the same time?
Yes. Bilateral carpal tunnel release (both hands in the same session) is safe and commonly performed under regional anaesthesia (bilateral wrist blocks). Having both hands operated on simultaneously means one recovery period instead of two. The main practical consideration is that both hands will be in dressings for the first 48–72 hours, during which you will need assistance with daily activities. Many patients find this more convenient than two separate operations weeks apart.
Will my carpal tunnel syndrome come back after surgery?
True recurrence after a complete ligament release is uncommon — approximately 3–5% over 10 years. Recurrence is more likely if the initial release was incomplete (technical failure), if underlying systemic conditions (diabetes, rheumatoid arthritis, hypothyroidism) are not adequately controlled, or if the patient returns to highly repetitive wrist-intensive activities without ergonomic modification. If symptoms return after surgery, repeat NCS should be performed to distinguish true recurrence from persistent symptoms from pre-existing severe nerve damage that is recovering slowly.